Shots:
New Year, New Us! Our hand-curated “Know Your Investor” reports will now be exploring leading investors of 2023
Founded in 2002, RA Capital forged ahead to become a key investor in life science and healthcare companies. In 2023, RA Capital closed 40 major investments in biopharma companies, devices, manufacturing, service offering firms, and diagnostics …
Shots:
Betty Woo, VP of Cell, Gene, and Advanced Therapies, Thermo Fisher Scientific discusses the evolution of ThermoFisher’s strategic collaboration with ArsenalBio
Betty highlights the development of programmable autologous T cells for the treatment of cancer and the cell therapy collaboration program
Betty believes that through innovation and partnership, they can tap into the full…
Shots:
Driven by the influx of life-changing innovations and technological advances, the pharmaceutical industry is forging ahead at a momentous pace. With the impelling Pharma 4.0, automation has now been embedded in various aspects of current business practices
Delving deeply into the importance of automation, primarily focusing on AI & ML, PharmaShots unveils its eight-step…

